WebSep 23, 2024 · This trial aims to analyse the safety and effectiveness of Inari's FlowTriever System for the removal of emboli from the pulmonary arteries in patients with acute … WebOct 18, 2024 · October 18, 2024—Inari Medical, Inc. announced planned enrollment of the PEERLESS randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the company’s FlowTriever system versus catheter-directed thrombolysis (CDT).
Giulia Castellani on LinkedIn: Transforming the understanding of …
WebMar 6, 2024 · Inari Medical’s FlowTriever System Studied in FLAME Trial for Treatment of High-Risk PE March 6, 2024—Inari Medical, Inc. announced results from the prospective … WebMar 6, 2024 · IRVINE, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering... how does hipot test work
Inari Medical Announces Three New Data Sets to be Presented
WebMar 6, 2024 · March 6, 2024—Inari Medical, Inc. announced results from the prospective FLAME study of the interventional treatment of high-risk/massive pulmonary embolism (PE) with the company’s FlowTriever system.. The FLAME investigators compared the outcomes of patients treated with FlowTriever versus those treated with other therapies in a context … WebApr 11, 2024 · The FLARE trial by Tu et al. evaluated the safety and effectiveness of percutaneous mechanical thrombectomy using the FlowTriever ® System in patients with acute intermediate-risk pulmonary embolism. Patients with symptomatic, computed tomography-documented PE and right ventricular (RV)/left ventricular (LV) ratios ≥0.9 … WebMar 6, 2024 · FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System By: Inari Medical, Inc. via Globe NewsWire March 06, 2024 at 08:00 AM EST photo learning center